Compound dexmedetomidine injection agent for dogs and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for dexmedetomidine and injections, applied in the field of compound dexmedetomidine injections for dogs and its preparation, to achieve the effects of increasing heart rate, reducing saliva secretion, and inhibiting muscle tremors
Inactive Publication Date: 2018-05-04
QINGDAO AGRI UNIV
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Based on the unique pharmacological action of dexmedetomidine, the present invention overcomes the influence of the existing compound anesthetics for animals on various organ systems of animals during use
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] A compound dexmedetomidine injection for dogs, the raw material formula is: dexmedetomidine 25 mg, droperidol 100 mg, atropine 10 mg, and 0.9% normal saline to 100 ml.
[0022] A method for preparing compound dexmedetomidine injection for dogs, comprising the following steps: dissolving dexmedetomidine, droperidol and atropine in 0.9% normal saline in sequence, adding 0.9% normal saline to dilute to 100ml , filtered, filled in ampoules, and sterilized.
Embodiment 2
[0024] A compound dexmedetomidine injection for dogs, the raw material formula is: dexmedetomidine 30mg, droperidol 100mg, atropine 13mg, 0.9% normal saline to 100ml.
[0025] A method for preparing compound dexmedetomidine injection for dogs, comprising the following steps: dissolving dexmedetomidine, droperidol, and atropine in an appropriate amount of 0.9% normal saline in sequence, and adding 0.9% normal saline to dilute to 100ml, filtered, filled in ampoules, and sterilized.
Embodiment 3
[0027] A compound dexmedetomidine injection for dogs, the raw material formula is: dexmedetomidine 35 mg, droperidol 150 mg, atropine 15 mg, and 0.9% normal saline to 100 ml.
[0028] A method for preparing compound dexmedetomidine injection for dogs, comprising the following steps: dissolving dexmedetomidine, droperidol, and atropine in an appropriate amount of 0.9% normal saline in sequence, and adding 0.9% normal saline to dilute to 100ml, filtered, filled in ampoules, and sterilized.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a compound dexmedetomidine injection agent for dogs and a preparation method thereof. The injection agent contains the active components including dexmedetomidine, droperidoland atropine. By integrating the advantages of each drug, the side effects caused during the single use of each drug is reduced, the rapid anesthesia induction is realized, the holding time is proper,and the dogs can rapidly revive; and the anesthesia process and the reviving process are smooth, and the injection agent is applicable to the immbilisation and induced anesthesia of the dogs. An injection provided by the invention is an intravenous medicine, can hardly influence each physiological parameter and can meet the anesthesia requirements in production practice, and furthermore, dexmedetomidine has certain protection effects to visceral organ systems such as nerves, heart and blood vessels and brain.
Description
technical field [0001] The invention belongs to the technical field of veterinary drug preparation, and in particular relates to a compound dexmedetomidine injection for dogs and a preparation method thereof. The compound dexmedetomidine injection for dogs is suitable for keeping and inducing anesthesia in dogs. Background technique [0002] The purpose of veterinary clinical anesthesia is to ensure the safety of humans and animals, eliminate pain and panic in animals, and facilitate the diagnosis and treatment of diseases. With the development of the pet industry, the influence of anesthetic drugs on various organs and tissues of animals has attracted more and more attention. The impact of anesthetics on the animal body and the safety of the time of use have become the mainstream of veterinary clinical research and development. [0003] At present, respiratory anesthesia has become the mainstream, and mask anesthesia is good, but it will increase some costs for pet owners ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more